Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Highland Management Partners VII, LLC. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Highland Management Partners VII, LLC har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:TDUP / ThredUp Inc. | 10% Owner | 51 540 |
US:CBLK / Carbon Black, Inc. | 10% Owner | 16 331 |
US:GIMO / Gigamon Inc. | 10% Owner | 53 448 |
US:TWOU / 2U, Inc. | 10% Owner | 0 |
US:HPTX / Hyperion Therapeutics Inc | 10% Owner | 38 616 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Highland Management Partners VII, LLC. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp TDUP / ThredUp Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i TDUP / ThredUp Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i TDUP / ThredUp Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Highland Management Partners VII, LLC som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class B Common Stock |
C - Conversion | −13 125 | 51 540 | −20,30 | ||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class B Common Stock |
C - Conversion | −151 950 | 576 297 | −20,87 | ||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class B Common Stock |
C - Conversion | −104 339 | 395 723 | −20,87 | ||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class B Common Stock |
C - Conversion | −430 586 | 1 633 061 | −20,87 | ||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
J - Other | −178 | 0 | −100,00 | ||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
J - Other | 178 | 178 | |||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
J - Other | −180 207 | 0 | −100,00 | ||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
J - Other | 180 207 | 180 207 | |||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
J - Other | −13 125 | 0 | −100,00 | ||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
J - Other | −151 950 | 0 | −100,00 | ||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
J - Other | −104 339 | 0 | −100,00 | ||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
J - Other | −430 586 | 0 | −100,00 | ||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
C - Conversion | 13 125 | 13 125 | |||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
C - Conversion | 151 950 | 151 950 | |||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
C - Conversion | 104 339 | 104 339 | |||||
2021-12-03 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
C - Conversion | 430 586 | 430 586 | |||||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class B Common Stock |
C - Conversion | −7 185 | 64 665 | −10,00 | ||||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class B Common Stock |
C - Conversion | −80 916 | 728 247 | −10,00 | ||||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class B Common Stock |
C - Conversion | −55 562 | 500 062 | −10,00 | ||||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class B Common Stock |
C - Conversion | −229 293 | 2 063 647 | −10,00 | ||||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
S - Sale | −7 185 | 0 | −100,00 | 23,16 | −166 396 | ||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
S - Sale | −80 916 | 0 | −100,00 | 23,16 | −1 873 917 | ||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
S - Sale | −55 562 | 0 | −100,00 | 23,16 | −1 286 749 | ||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
S - Sale | −229 293 | 0 | −100,00 | 23,16 | −5 310 151 | ||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
C - Conversion | 7 185 | 7 185 | |||||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
C - Conversion | 80 916 | 80 916 | |||||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
C - Conversion | 55 562 | 55 562 | |||||
2021-08-02 |
|
4 | TDUP |
ThredUp Inc.
Class A Common Stock |
C - Conversion | 229 293 | 229 293 | |||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series F Preferred Stock |
C - Conversion | −882 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series F Preferred Stock |
C - Conversion | −9 928 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series F Preferred Stock |
C - Conversion | −6 817 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series F Preferred Stock |
C - Conversion | −28 132 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series E-1 Preferred Stock |
C - Conversion | −3 771 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series E-1 Preferred Stock |
C - Conversion | −42 469 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series E-1 Preferred Stock |
C - Conversion | −29 162 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series E-1 Preferred Stock |
C - Conversion | −120 344 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series E Preferred Stock |
C - Conversion | −7 219 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series E Preferred Stock |
C - Conversion | −81 297 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series E Preferred Stock |
C - Conversion | −55 824 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series E Preferred Stock |
C - Conversion | −230 374 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series D Preferred Stock |
C - Conversion | −11 420 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series D Preferred Stock |
C - Conversion | −128 611 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series D Preferred Stock |
C - Conversion | −88 313 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series D Preferred Stock |
C - Conversion | −364 449 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series C Preferred Stock |
C - Conversion | −42 100 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series C Preferred Stock |
C - Conversion | −474 136 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series C Preferred Stock |
C - Conversion | −325 572 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series C Preferred Stock |
C - Conversion | −1 343 565 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series A-1 Preferred Stock |
C - Conversion | −2 265 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series A-1 Preferred Stock |
C - Conversion | −25 511 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series A-1 Preferred Stock |
C - Conversion | −17 518 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series A-1 Preferred Stock |
C - Conversion | −72 292 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series A Preferred Stock |
C - Conversion | −3 458 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series A Preferred Stock |
C - Conversion | −38 939 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series A Preferred Stock |
C - Conversion | −26 738 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Series A Preferred Stock |
C - Conversion | −110 343 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Common Stock |
J - Other | −735 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Common Stock |
J - Other | −8 272 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Common Stock |
J - Other | −5 680 | 0 | −100,00 | ||||
2021-04-01 |
|
4 | TDUP |
ThredUp Inc.
Common Stock |
J - Other | −23 441 | 0 | −100,00 | ||||
2021-03-25 | 3 | TDUP |
ThredUp Inc.
Common Stock |
23 441 | ||||||||
2021-03-25 | 3 | TDUP |
ThredUp Inc.
Common Stock |
5 680 | ||||||||
2021-03-25 | 3 | TDUP |
ThredUp Inc.
Common Stock |
8 272 | ||||||||
2021-03-25 | 3 | TDUP |
ThredUp Inc.
Common Stock |
735 | ||||||||
2018-12-14 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −9 362 | 16 331 | −36,44 | ||||
2018-12-14 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −105 428 | 183 940 | −36,43 | ||||
2018-12-14 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −72 394 | 126 304 | −36,43 | ||||
2018-12-14 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −298 754 | 521 234 | −36,43 | ||||
2018-12-14 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −57 792 | 100 829 | −36,43 | ||||
2018-12-14 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −639 653 | 1 116 002 | −36,43 | ||||
2018-12-14 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −1 166 810 | 2 035 739 | −36,43 | ||||
2018-12-06 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −8 565 | 25 693 | −25,00 | ||||
2018-12-06 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −96 456 | 289 368 | −25,00 | ||||
2018-12-06 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −66 233 | 198 698 | −25,00 | ||||
2018-12-06 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −273 330 | 819 988 | −25,00 | ||||
2018-12-06 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −52 874 | 158 621 | −25,00 | ||||
2018-12-06 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −585 219 | 1 755 655 | −25,00 | ||||
2018-12-06 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
J - Other | −1 067 516 | 3 202 549 | −25,00 | ||||
2018-05-11 | 3/A | CBLK |
Carbon Black, Inc.
Common Stock |
755 904 | ||||||||
2018-05-11 | 3/A | CBLK |
Carbon Black, Inc.
Common Stock |
414 297 | ||||||||
2018-05-11 | 3/A | CBLK |
Carbon Black, Inc.
Common Stock |
37 436 | ||||||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series F Convertible Preferred Stock |
C - Conversion | −32 486 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series F Convertible Preferred Stock |
C - Conversion | −365 866 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series F Convertible Preferred Stock |
C - Conversion | −251 227 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series F Convertible Preferred Stock |
C - Conversion | −1 036 762 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series E Convertible Preferred Stock |
C - Conversion | −36 031 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series E Convertible Preferred Stock |
C - Conversion | −405 783 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series E Convertible Preferred Stock |
C - Conversion | −278 637 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series E Convertible Preferred Stock |
C - Conversion | −1 149 874 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series D Convertible Preferred Stock |
C - Conversion | −34 166 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series D Convertible Preferred Stock |
C - Conversion | −378 171 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series D Convertible Preferred Stock |
C - Conversion | −689 800 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series C Convertible Preferred Stock |
C - Conversion | −76 480 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series C Convertible Preferred Stock |
C - Conversion | −846 518 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series C Convertible Preferred Stock |
C - Conversion | −1 544 087 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series B Convertible Preferred Stock |
C - Conversion | −237 472 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series B Convertible Preferred Stock |
C - Conversion | −2 628 466 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Series B Convertible Preferred Stock |
C - Conversion | −4 794 437 | 0 | −100,00 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
C - Conversion | 34 258 | 34 258 | |||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
C - Conversion | 385 824 | 385 824 | |||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
C - Conversion | 264 931 | 264 931 | |||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
C - Conversion | 1 093 318 | 1 093 318 | |||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
C - Conversion | 174 059 | 211 495 | 464,95 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
C - Conversion | 1 926 577 | 2 340 874 | 465,02 | ||||
2018-05-10 |
|
4 | CBLK |
Carbon Black, Inc.
Common Stock |
C - Conversion | 3 514 161 | 4 270 065 | 464,90 | ||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 963 541 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 621 934 | ||||||||
2018-05-03 | 3 | CBLK |
Carbon Black, Inc.
Common Stock |
1 245 073 | ||||||||
2015-04-30 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
J - Other | −28 897 | 53 448 | −35,09 | ||||
2015-04-30 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
J - Other | −325 438 | 601 952 | −35,09 | ||||
2015-04-30 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
J - Other | −223 467 | 413 338 | −35,09 | ||||
2015-04-30 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
J - Other | −922 198 | 1 705 762 | −35,09 | ||||
2015-02-20 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
J - Other | −28 897 | 82 345 | −25,98 | ||||
2015-02-20 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
J - Other | −325 438 | 927 390 | −25,98 | ||||
2015-02-20 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
J - Other | −223 467 | 636 805 | −25,98 | ||||
2015-02-20 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
J - Other | −922 198 | 2 627 960 | −25,98 | ||||
2014-04-02 |
|
4 | TWOU |
2U, Inc.
Series D Preferred Stock |
C - Conversion | −319 914 | 0 | −100,00 | ||||
2014-04-02 |
|
4 | TWOU |
2U, Inc.
Series C Preferred Stock |
C - Conversion | −475 899 | 0 | −100,00 | ||||
2014-04-02 |
|
4 | TWOU |
2U, Inc.
Series B Preferred Stock |
C - Conversion | −2 747 352 | 0 | −100,00 | ||||
2014-04-02 |
|
4 | TWOU |
2U, Inc.
Common Stock |
C - Conversion | 319 914 | 319 914 | |||||
2014-04-02 |
|
4 | TWOU |
2U, Inc.
Common Stock |
C - Conversion | 475 899 | 475 899 | |||||
2014-04-02 |
|
4 | TWOU |
2U, Inc.
Common Stock |
C - Conversion | 2 747 352 | 2 747 352 | |||||
2013-10-28 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
S - Sale | −35 453 | 111 242 | −24,17 | 38,50 | −1 364 940 | 4 282 817 | |
2013-10-28 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
S - Sale | −399 279 | 1 252 828 | −24,17 | 38,50 | −15 372 242 | 48 233 878 | |
2013-10-28 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
S - Sale | −274 171 | 860 272 | −24,17 | 38,50 | −10 555 584 | 33 120 472 | |
2013-10-28 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
S - Sale | −1 131 444 | 3 550 158 | −24,17 | 38,50 | −43 560 594 | 136 681 083 | |
2013-09-23 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −83 | 38 616 | −0,21 | 25,81 | −2 142 | 996 679 | |
2013-09-23 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −933 | 435 013 | −0,21 | 25,81 | −24 081 | 11 227 686 | |
2013-09-23 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −641 | 298 707 | −0,21 | 25,81 | −16 544 | 7 709 628 | |
2013-09-23 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −2 643 | 1 232 721 | −0,21 | 25,81 | −68 216 | 31 816 529 | |
2013-09-23 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −28 | 38 699 | −0,07 | 25,93 | −726 | 1 003 465 | |
2013-09-23 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −315 | 435 946 | −0,07 | 25,93 | −8 168 | 11 304 080 | |
2013-09-23 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −217 | 299 348 | −0,07 | 25,93 | −5 627 | 7 762 094 | |
2013-09-23 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −894 | 1 235 364 | −0,07 | 25,93 | −23 181 | 32 032 989 | |
2013-09-19 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −111 | 38 727 | −0,29 | 26,03 | −2 889 | 1 008 064 | |
2013-09-19 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −1 252 | 436 261 | −0,29 | 26,03 | −32 590 | 11 355 874 | |
2013-09-19 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −860 | 299 565 | −0,29 | 26,03 | −22 386 | 7 797 677 | |
2013-09-19 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −3 547 | 1 236 258 | −0,29 | 26,03 | −92 328 | 32 179 796 | |
2013-09-19 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −188 | 38 838 | −0,48 | 25,99 | −4 886 | 1 009 400 | |
2013-09-19 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −2 121 | 437 513 | −0,48 | 25,99 | −55 125 | 11 370 963 | |
2013-09-19 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −1 456 | 300 425 | −0,48 | 25,99 | −37 841 | 7 808 046 | |
2013-09-19 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −6 009 | 1 239 805 | −0,48 | 25,99 | −156 174 | 32 222 532 | |
2013-09-17 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −119 | 39 026 | −0,30 | 26,22 | −3 120 | 1 023 262 | |
2013-09-17 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −1 345 | 439 634 | −0,31 | 26,22 | −35 266 | 11 527 203 | |
2013-09-17 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −924 | 301 881 | −0,31 | 26,22 | −24 227 | 7 915 320 | |
2013-09-17 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −3 812 | 1 245 814 | −0,31 | 26,22 | −99 951 | 32 665 243 | |
2013-09-17 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −40 | 39 145 | −0,10 | 26,50 | −1 060 | 1 037 342 | |
2013-09-17 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −456 | 440 979 | −0,10 | 26,50 | −12 084 | 11 685 944 | |
2013-09-17 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −313 | 302 805 | −0,10 | 26,50 | −8 294 | 8 024 332 | |
2013-09-17 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −1 291 | 1 249 626 | −0,10 | 26,50 | −34 212 | 33 115 089 | |
2013-09-12 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −88 | 39 185 | −0,22 | 27,08 | −2 383 | 1 061 130 | |
2013-09-12 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −992 | 441 435 | −0,22 | 27,08 | −26 863 | 11 954 060 | |
2013-09-12 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −681 | 303 118 | −0,22 | 27,08 | −18 441 | 8 208 435 | |
2013-09-12 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −2 812 | 1 250 917 | −0,22 | 27,08 | −76 149 | 33 874 832 | |
2013-09-12 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −578 | 39 273 | −1,45 | 26,48 | −15 305 | 1 039 949 | |
2013-09-12 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −6 509 | 442 427 | −1,45 | 26,48 | −172 358 | 11 715 467 | |
2013-09-12 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −4 469 | 303 799 | −1,45 | 26,48 | −118 339 | 8 044 598 | |
2013-09-12 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −18 444 | 1 253 729 | −1,45 | 26,48 | −488 397 | 33 198 744 | |
2013-09-10 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −346 | 39 851 | −0,86 | 26,06 | −9 017 | 1 038 517 | |
2013-09-10 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −3 894 | 448 936 | −0,86 | 26,06 | −101 478 | 11 699 272 | |
2013-09-10 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −2 674 | 308 268 | −0,86 | 26,06 | −69 684 | 8 033 464 | |
2013-09-10 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −11 034 | 1 272 173 | −0,86 | 26,06 | −287 546 | 33 152 828 | |
2013-09-10 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −2 | 40 197 | 0,00 | 25,50 | −51 | 1 025 024 | |
2013-09-10 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −22 | 452 830 | 0,00 | 25,50 | −561 | 11 547 165 | |
2013-09-10 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −15 | 310 942 | 0,00 | 25,50 | −382 | 7 929 021 | |
2013-09-10 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −61 | 1 283 207 | 0,00 | 25,50 | −1 556 | 32 721 778 | |
2013-08-07 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −482 | 40 199 | −1,18 | 25,48 | −12 281 | 1 024 271 | |
2013-08-07 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −5 424 | 452 852 | −1,18 | 25,48 | −138 204 | 11 538 669 | |
2013-08-07 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −3 725 | 310 957 | −1,18 | 25,48 | −94 913 | 7 923 184 | |
2013-08-07 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −15 369 | 1 283 268 | −1,18 | 25,48 | −391 602 | 32 697 669 | |
2013-08-05 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −52 | 40 681 | −0,13 | 25,37 | −1 319 | 1 032 077 | |
2013-08-05 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −587 | 458 276 | −0,13 | 25,37 | −14 892 | 11 626 462 | |
2013-08-05 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −403 | 314 682 | −0,13 | 25,37 | −10 224 | 7 983 482 | |
2013-08-05 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −1 665 | 1 298 637 | −0,13 | 25,37 | −42 241 | 32 946 421 | |
2013-08-05 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −858 | 40 733 | −2,06 | 25,35 | −21 750 | 1 032 582 | |
2013-08-05 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −9 663 | 458 863 | −2,06 | 25,35 | −244 957 | 11 632 177 | |
2013-08-05 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −6 635 | 315 085 | −2,06 | 25,35 | −168 197 | 7 987 405 | |
2013-08-05 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
S - Sale | −27 382 | 1 300 302 | −2,06 | 25,35 | −694 134 | 32 962 656 | |
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Series A Preferred Stock |
C - Conversion | −156 231 | 0 | −100,00 | ||||
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Series A Preferred Stock |
C - Conversion | −1 759 502 | 0 | −100,00 | ||||
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Series A Preferred Stock |
C - Conversion | −1 208 187 | 0 | −100,00 | ||||
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Series A Preferred Stock |
C - Conversion | −4 985 927 | 0 | −100,00 | ||||
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
S - Sale | −9 536 | 146 695 | −6,10 | 17,67 | −168 501 | 2 592 101 | |
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
S - Sale | −107 395 | 1 652 107 | −6,10 | 17,67 | −1 897 670 | 29 192 731 | |
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
S - Sale | −73 744 | 1 134 443 | −6,10 | 17,67 | −1 303 056 | 20 045 608 | |
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
S - Sale | −304 325 | 4 681 602 | −6,10 | 17,67 | −5 377 423 | 82 723 907 | |
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
C - Conversion | 156 231 | 156 231 | |||||
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
C - Conversion | 1 759 502 | 1 759 502 | |||||
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
C - Conversion | 1 208 187 | 1 208 187 | |||||
2013-06-17 |
|
4 | GIMO |
Gigamon Inc.
Common Stock |
C - Conversion | 4 985 927 | 4 985 927 | |||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −150 318 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-1 Preferred Stock |
C - Conversion | −132 601 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −262 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −262 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
J - Other | −6 658 | 262 | −96,21 | 10,00 | −66 580 | 2 620 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
J - Other | −6 658 | 262 | −96,21 | 10,00 | −66 580 | 2 620 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
X - Other | 6 920 | 6 920 | |||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
X - Other | 6 920 | 6 920 | |||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Preferred Stock |
X - Other | −6 920 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Preferred Stock |
X - Other | −6 920 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Common Stock |
X - Other | −16 119 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-1 Preferred Stock |
C - Conversion | −375 755 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −103 218 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-1 Preferred Stock |
C - Conversion | −91 052 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −1 085 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −1 085 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
J - Other | −27 472 | 1 085 | −96,20 | 10,00 | −274 720 | 10 850 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
J - Other | −27 472 | 1 085 | −96,20 | 10,00 | −274 720 | 10 850 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
X - Other | 28 557 | 28 557 | |||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
X - Other | 28 557 | 28 557 | |||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Preferred Stock |
X - Other | −28 557 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Preferred Stock |
X - Other | −28 557 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Common Stock |
X - Other | −66 522 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −425 958 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
P - Purchase | 21 696 | 468 526 | 4,86 | 10,00 | 216 960 | 4 685 260 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 382 | 446 830 | 0,09 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 382 | 446 830 | 0,09 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
J - Other | −9 578 | 446 066 | −2,10 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
X - Other | 23 475 | 455 644 | 5,43 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 33 253 | 432 169 | 8,34 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 33 811 | 398 916 | 9,26 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 81 334 | 365 105 | 28,66 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 150 318 | 283 771 | 112,64 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 132 601 | 133 453 | 15 563,50 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
P - Purchase | 14 898 | 321 720 | 4,86 | 10,00 | 148 980 | 3 217 200 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 262 | 306 822 | 0,09 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 262 | 306 822 | 0,09 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
J - Other | −6 577 | 306 298 | −2,10 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
X - Other | 16 119 | 312 875 | 5,43 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 22 834 | 296 756 | 8,34 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 23 217 | 273 922 | 9,26 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 55 849 | 250 705 | 28,66 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 103 218 | 194 856 | 112,64 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 91 052 | 91 638 | 15 537,88 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
P - Purchase | 61 480 | 1 327 684 | 4,86 | 10,00 | 614 800 | 13 276 840 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 1 085 | 1 266 204 | 0,09 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 1 085 | 1 266 204 | 0,09 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
J - Other | −27 141 | 1 264 034 | −2,10 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
X - Other | 66 522 | 1 291 175 | 5,43 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 94 231 | 1 224 653 | 8,34 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 95 812 | 1 130 422 | 9,26 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 230 478 | 1 034 610 | 28,66 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 425 958 | 804 132 | 112,64 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 375 755 | 378 174 | 15 533,48 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −33 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −33 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
J - Other | −861 | 33 | −96,31 | 10,00 | −8 610 | 330 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
J - Other | −861 | 33 | −96,31 | 10,00 | −8 610 | 330 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
X - Other | 894 | 894 | |||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
X - Other | 894 | 894 | |||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Preferred Stock |
X - Other | −894 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Preferred Stock |
X - Other | −894 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Common Stock |
X - Other | −2 084 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −13 346 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-1 Preferred Stock |
C - Conversion | −11 773 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −382 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
C - Conversion | −382 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
J - Other | −9 695 | 382 | −96,21 | 10,00 | −96 950 | 3 820 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
J - Other | −9 695 | 382 | −96,21 | 10,00 | −96 950 | 3 820 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
X - Other | 10 077 | 10 077 | |||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Series C-2 Preferred Stock |
X - Other | 10 077 | 10 077 | |||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Preferred Stock |
X - Other | −10 077 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Preferred Stock |
X - Other | −10 077 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Warrant to Purchase Common Stock |
X - Other | −23 475 | 0 | −100,00 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Convertible Promissory Note |
C - Conversion | 0 | ||||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
P - Purchase | 1 926 | 41 591 | 4,86 | 10,00 | 19 260 | 415 910 | |
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 33 | 39 665 | 0,08 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 33 | 39 665 | 0,08 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
J - Other | −851 | 39 599 | −2,10 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
X - Other | 2 084 | 40 450 | 5,43 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 2 952 | 38 366 | 8,34 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 3 002 | 35 414 | 9,26 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 7 221 | 32 412 | 28,66 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 13 346 | 25 191 | 112,67 | ||||
2012-08-02 |
|
4 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
C - Conversion | 11 773 | 11 845 | 16 351,39 | ||||
2012-07-25 | 3 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
2 419 | ||||||||
2012-07-25 | 3 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
586 | ||||||||
2012-07-25 | 3 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
852 | ||||||||
2012-07-25 | 3 | HPTX |
HYPERION THERAPEUTICS INC
Common Stock |
72 |